Pharmaceutical Glass Packaging Market

Market Definition

The Pharmaceutical Glass Packaging Market size was valued at USD 20.80 billion in 2023 and is predicted to reach USD 39.26 billion by 2030 with a CAGR of 9.5% from 2024-2030. Pharmaceutical glass serves as a sustainable and environmentally friendly solution for storing strong alkalis and acids. Its recyclable and refillable nature, combined with its resistance to temperature changes and atmospheric gases, makes it a preferred choice for pharmaceutical packaging. Composed primarily of silica, with small amounts of boric oxide, sodium oxide, and aluminium oxide, pharmaceutical glass ensures drug stability by preventing the escape of volatile ingredients and minimizing the risk of contamination. Its durability and impermeability make it suitable for bulk transportation and safeguarding products during storage.

Market Dynamics and Trends

The pharmaceutical industry is witnessing a surge in demand for medicines and healthcare products worldwide, primarily due to the increasing prevalence of chronic diseases. This heightened demand is driving the need for efficient packaging solutions, thereby fueling the growth of the pharmaceutical glass packaging market. According to the World Health Organization (WHO) in 2021, cardiovascular diseases accounted for 17.9 million people’s deaths, followed by 9.3 million deaths by cancer, 4.1 million deaths by chronic respiratory diseases, and 2.0 million deaths by kidney disease deaths caused by diabetes.

Additionally, Advancements in technology, such as moisture and air-proof boron-free glass, along with modifications in packaging styles, such as radiofrequency identification technology and child-resistant technology, are expected to boost the growth of the market. These technologies are aimed at enhancing the safety, efficiency, and convenience of pharmaceutical packaging, thereby meeting the evolving needs of the industry and consumers. For instance, in May 2022, Bormioli Pharma in collaboration with Italian research centre IMEM-CNR, to develop an external and internal coatings in glass to enhance their performance and make soda-lime glass bottles progressively resilient to hostile pharmaceutical formulations.

However, availability of cheap alternative plastic packaging may hinder the expansion of the pharmaceutical glass packaging market. On the contrary, the introduction of 3D printing technology, along with advancements in sustainable materials such as bio-based or recycled glass, is anticipated to create numerous opportunities for market growth. These technologies enable more flexible and customized manufacturing processes, allowing for the production of innovative packaging designs tailored to specific pharmaceutical products. 

Market Segmentation and Scope of Study

The Pharmaceutical glass packaging market is segmented on the basis of material, product drug type, and region. On the basis of material, the market is classified into type I, type II and type III. On the basis of product, the market is classified into Ampoules, Bottles, Vials, Syringes and Cartridges. On the basis of drug type, the market is classified into Generic, Branded, Biologic. Regional breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and rest of the world.

Geographical Analysis

The North America region holds the dominant share in pharmaceutical glass packaging market at present and is expected to further expand the market size during the forecasted period. The growing prevalence of chronic diseases in North America is driving the growth of the pharmaceutical glass packaging market. According to the latest report published by the Centers for Disease Control and Prevention, chronic diseases are among the leading causes of death in the U.S., with over 133 million people suffering from at least one chronic disease. This increasing prevalence of chronic conditions necessitates the production and packaging of a wide range of pharmaceutical products, including medications and treatments, leading to higher demand for pharmaceutical glass packaging solutions in the region.

Moreover, the presence of major players in this region such as Owens Illinois Inc., Ardagh Packaging Group PLC, Stevanato Group (Ompi), Piramal glass limited, Amcor Limited, Gerresheimer AG, Aptar Group and others. For instance, German pharmaceutical packaging supplier Gerresheimer announced an investment of 94 million USD to increase its glass manufacturing, supply and logistics capability for glass vials in the US.

On the other hand, Asia Pacific is anticipated to show a steady growth in the pharmaceutical glass packaging market due to the rapidly expanding population in the region, which is increasingly susceptible to chronic diseases. According to the latest report published by the International Monetary Fund, Asia Pacific accounts for more than 50% of the global population, with India's population reaching 1.44 billion followed by China with 1.41 billion in 2023. This large and growing population presents a significant demand for pharmaceutical products, driving the need for reliable and efficient packaging solutions such as pharmaceutical glass packaging.

Moreover, the rapidly growing pharmaceutical industry in the region, further driving the growth of the market. According to the latest report published by the government of China, the pharmaceutical industry is one of the largest sectors in China, accounting for more than 30% of global production. This robust growth in the pharmaceutical sector in Asia Pacific fuels the demand for pharmaceutical glass packaging solutions, driving the expansion of the market in the region.

Competitive Landscape

Various market players operating in the pharmaceutical glass packaging market include Ardagh Group S.A., Bormioli Pharma S.R.L., Piramal Glass Private Limited, Schott AG, Sisecam, Owens-Illinois Inc., Amcor Limited, Gerresheimer AG, West Pharmaceutical Services Inc., Nipro Corporation, and others. These market players are adopting various strategies including acquisition and partnerships to maintain their dominance in the pharmaceutical glass packaging market.

For instance, in October 26, 2022, Nipro Corporation has announced that it has established a medical device sales subsidiary in the Republic of the Philippines. Through this expansion, the company aims to strengthen its presence and distribution network in the Philippine market.

Moreover, in January 2022, West Pharmaceutical Services Inc. revealed an exclusive supply and technology agreement with Corning Incorporated. The partnership aims to extend Corning's Valor Glass technology for advanced packaging and transport systems for injectable medicines in pharmaceutical manufacturing.

KEY BENEFITS

• The report provides quantitative analysis and estimations of the pharmaceutical glass packaging market from 2024 to 2030, which assists in identifying the prevailing market opportunities.

• The study comprises a deep-dive analysis of the pharmaceutical glass packaging market including the current and future trends to depict prevalent investment pockets in the market.

• Information related to key drivers, restraints, and opportunities and their impact on the pharmaceutical glass packaging market is provided in the report. 

• Competitive analysis of the players, along with their market share is provided in the report.

• SWOT analysis and Porters Five Forces model is elaborated in the study.

• Value chain analysis in the market study provides a clear picture of roles of stakeholders.

KEY MARKET SEGMENTS

By Material

• Type I

• Type II

• Type III

By Product

• Ampoules

• Bottles

• Vials

• Syringes

• Cartridges

By Drug Type

• Generic

• Branded

• Biologic

By Region 

• North America

  • The U.S

  • Canada

  • Mexico

• Europe

  • The UK

  • Germany

  • France    

  • Italy

  • Spain

  • Denmark

  • Netherlands

  • Finland

  • Sweden

  • Norway

  • Russia

  • Rest of Europe

• Asia-Pacific

  • China

  • Japan

  •  India

  • South Korea

  • Australia

  • Indonesia

  • Singapore

  •  Taiwan

  •  Thailand 

  • Rest of Asia-Pacific

• RoW

  • Latin America

  • Middle East

  • Africa

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Market Size in 2023	USD 20.80 Billion
Revenue Forecast in 2030	USD 39.26 Billion
Growth Rate	CAGR of 9.5% from 2024 to 2030
Analysis Period	2023–2030
Base Year Considered	2023
Forecast Period	2024–2030
Market Size Estimation	Billion (USD)
Growth Factors	Growing prevalence of Chronic disease globally Advancement in technology drives the market
Countries Covered	28
Companies Profiled	10
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

KEY PLAYERS

• Ardagh Group S.A. 

• Bormioli Pharma S.R.L.

• Piramal Glass Private Limited

• Schott AG

• Sisecam

• Owens-Illinois Inc

• Amcor Limited

• Gerresheimer AG

• West Pharmaceutical Services Inc.

• Nipro Corporation